Tradestie Institutional Equity Comparison Engine

VVOS vs TPST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TPST Overall Edge

TPST Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tempest Therapeutics, Inc. Common Stock (TPST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus TPST at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against TPST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VVOS N/M vs TPST N/M Fwd P/E
Growth & Margin Winner TPST
Op Margin -107.9% vs 0.0% ยท YoY +34.9% vs +0.0%
Momentum & Technical Winner TPST
1Y -97.7% vs -94.0% ยท 52W Pos 0% vs 0%
Options & Structure Winner TPST
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VVOS NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap $1.9M
1M Return -59.25%
1Y Return -97.71%
Forward P/E N/M
Unified AI Score
36.4 / 100 SELL
Tech 25.0 Fund 35.0 Flow 50.0 Mom 30.0
TPST NASDAQ
Tempest Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$0.29
-6.18% 1D
Market Cap $6.1M
1M Return -45.05%
1Y Return -93.96%
Forward P/E N/M
Unified AI Score
39.2 / 100 SELL
Tech 25.0 Fund 44.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VVOS -97.71% TPST -93.96% Spread: +3.75 pp (TPST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VVOS Revenue TPST Revenue VVOS Op. Margin TPST Op. Margin Margin Edge
FY2017 N/A $0M N/A -28585.1% TPST
FY2019 $10M N/A -92.8% N/A VVOS
FY2020 $10M N/A -92.1% N/A VVOS
FY2021 $20M N/A -120.7% N/A VVOS
FY2022 $20M N/A -156.2% N/A VVOS
FY2023 $10M N/A -125.3% N/A VVOS
FY2024 $20M N/A -74.3% N/A VVOS
FY2025 $20M N/A -114.1% N/A VVOS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VVOS (1) vs TPST (5)
Institutional Metric VVOS TPST Criterion Row Winner
Market Capitalization Scale $1.9M $6.1M Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +34.9% +0.0% Higher Growth VVOS
Operating Margin (TTM) Profitability -107.9% 0.0% Higher Margin TPST
Net Profit Margin Profitability -121.8% 0.0% Higher Margin TPST
Return on Equity (ROE) Capital Efficiency -8585.3% -1797.6% Higher ROE TPST
52-Week Range Position Momentum 0% ($0โ€“$3) 0% ($0โ€“$9) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.70ฮฒ ยท 111% Vol 0.77ฮฒ ยท 85% Vol Lower Realized Risk TPST
Unified Institutional Score Composite Signal 36.4 / 100 (SELL) 39.2 / 100 (SELL) Higher Composite TPST

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VVOS vs TPST Buy Guide
VVOS BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VVOS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TPST UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live TPST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VVOS nor TPST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.